April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

• Sandoz discontinued their metaxalone presentations in 2010. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=787 Source: www.ashp.org Lidocaine with Epinephrine Injection March 7, 2012 Products Affected - Description Lidocaine 0.5% with epinephrine Xylocaine 0.5% (with epinephrine 1:200,000 injection), APP 5 mg/mL, 50 mL vial (NDC 63323-0481-57) Lidocaine 1% with epinephrine Xylocaine 1% (with epinephrine 1:200,000 injection), APP 10 mg/mL, 10 mL vial (NDC 63323-0482-17) 10 mg/mL, 20 mL vial (NDC 63323-0482-27) 10 mg/mL, 50 mL vial (NDC 63323-0482-57) Xylocaine 1% - MPF (with epinephrine 1:200,000 injection), APP 10 mg/mL, 10 mL vial (NDC 63323-0487-17) 10 mg/mL, 30 mL vial (NDC 63323-0487-37) 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0487-31) Lidocaine 1% (with epinephrine 1:100,000) injection, Hospira 10 mg/mL, 50 mL vial (NDC 00409-3178-03) Lidocaine 1.5% with epinephrine Xylocaine 1.5% - MPF (with epinephrine 1:200,000 injection), APP 15 mg/mL, 10 mL vial (NDC 63323-0488-17) 15 mg/mL, 30 mL vial (NDC 63323-0488-37) Lidocaine 1.5% (with epinephrine 1:200,000 injection), Hospira 15 mg/mL, 5 mL glass ampule, 100 count (NDC 00409-1209-65) 15 mg/mL, 30 mL vial (NDC 00409-3181-01) Lidocaine 2% with epinephrine Xylocaine 2% (with epinephrine 1:200,000 injection), APP 20 mg/mL, 20 mL vial (NDC 63323-0483-27) 20 mg/mL, 50 mL vial (NDC 63323-0483-57) Xylocaine 2% - MPF (with epinephrine 1:200,000 injection), APP 20 mg/mL, 10 mL vial (NDC 63323-0489-17) 20 mg/mL, 20 mL vial (NDC 63323-0489-27) 20 mg/mL, 20 mL vial, sterile pack (NDC 63323-0489-21) Lidocaine 2% (with epinephrine 1:100,000 injection), Hospira 20 mg/mL, 30 mL vial (NDC 00409-3182-02) 20 mg/mL, 50 mL vial (NDC 00409-3182-03) Reason for the Shortage • Hospira has lidocaine with epinephrine presentations on shortage due to manufacturing delays. • APP has Xylocaine with epinephrine presentations on shortage due to increased demand for the product. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=860 Source: www.ashp.org Ganciclovir Capsules March 7, 2012 38
Products Affected - Description Ganciclovir sodium capsules, Ranbaxy 250 mg capsules, 180 count bottles (NDC 63304-0636-28) 500 mg capsules, 180 count bottles (NDC 63304-0637-28) Reason for the Shortage • Ganciclovir capsules are on back order due to a raw material shortage.1 There are no other suppliers of ganciclovir tablets. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=539 Source: www.ashp.org Fluorouracil Injection March 7, 2012 Products Affected - Description Fluorouracil injection 50 mg/mL, Mylan Institutional 10 mL vial (NDC 10139-0063-11) 20 mL vial (NDC 10139-0063-12) 50 mL vial (NDC 10139-0063-50) 100 mL vial (NDC 10139-0063-01) Reason for the Shortage • APP states fluorouracil is on allocation to prevent excessive purchases. • Teva states their fluorouracil shortage was due to manufacturing delays. • Mylan Institutional states the reason for the shortage is that demand exceeds supply due to market conditions. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=798 Source: www.ashp.org Caffeine and Sodium Benzoate Injection March 8, 2012 Products Affected - Description Caffeine, anhydrous (125 mg/mL) / Sodium benzoate (125 mg/mL), American Regent 2 mL single-dose vial, package of 10 (NDC 00517-2502-10) Reason for the Shortage • American Regent had temporarily suspended manufacture of multiple drug products including caffeine and sodium benzoate injection in April, 2011.1 • America Regent has recalled one lot (Lot #0084, expiration date: February, 2012) of caffeine and sodium benzoate injection due to the potential of particles in the vials.1 • American Regent resumed manufacturing in Shirley, New York in early-May, 2011.1 • American Regent is the sole manufacturer of caffeine and sodium benzoate injection. • Caffeine citrate injection is not affected by this shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=817 Source: www.ashp.org Valproate Sodium Injection March 9, 2012 Products Affected - Description Valproate injection, Bedford 100 mg/mL, 5 mL vials (NDC 55390-0007-10) Reason for the Shortage 39
Page 1 and 2: April 2012 Drug Information Update
Page 3 and 4: First-Time Generics GENERIC DRUG NA
Page 5 and 6: GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37: Reason for the Shortage • Ben Ven
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73 and 74: Nicardipine hydrochloride injection
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F

April 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?